Please use this identifier to cite or link to this item:
Title: Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Issue Date: 19-Aug-2015
Citation: BMC Neurol.2015 Aug;(15):141
Abstract: In the treatment of multiple sclerosis, a change of therapy is considered after treatment failure or adverse events. Although disease modifying drugs' (DMD) efficacy and side effects have been fully analysed in clinical trials, the effects of previous therapy use are less well studied. We aimed to study medication persistence with glatiramer acetate in treatment-naive patients and in patients previously treated with interferon.
PMID: 26286576
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC4545781.pdf874.56 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.